Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A simple bioreactor-based method to generate kidney organoids from pluripotent stem cells
A provider should help decide whether established GLP-1 weight loss drugs or other obesity treatment medications fit the patients needs
Mito-tempo ameliorates tubular injury of diabetic nephropathy via inhibiting mt-dsRNA release and PKR/eIF2alpha pathway activation
This ingredient can enhance physical and mental performance by increasing acetylcholine and supporting lipid metabolism [21, 22]
Cochrane Database of Systematic Reviews, 11 (11), CD015385
US$ 22.56
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 26.38
US$ 22.35
US$ 20.45
US$ 23.63
US$ 29.49
